PharVision Advisers
TASK icon

PharVision Advisers’s TaskUs TASK Stock Holding History

PharVision Advisers’s Portfolio TASK Stock Details TASK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-11,056
Closed -$51.7K – 70
2026
Q2 		$51.7K Buy
+11,056
New +$67.1K 0.98% 58
2026
Q1 		– Sell
-22,193
Closed -$262K – 586
2025
Q4 		$262K Buy
+22,193
New +$284K 0.13% 363
2025
Q2 		– Sell
-17,245
Closed -$235K – 425
2025
Q1 		$235K Buy
+17,245
New +$259K 0.33% 149

Other funds holding TASK

Dalton Investments
Dalton Investments Las Vegas, Nevada $149M AUM 9.24% 1-Year Est. Return
Brooklands Fund Management
Brooklands Fund Management London, United Kingdom $782M AUM 0.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Symmetry Partners
Symmetry Partners Glastonbury, Connecticut $1.96B AUM 12.39% 1-Year Est. Return
HUB Investment Partners
HUB Investment Partners Austin, Texas $5.8B AUM 24.38% 1-Year Est. Return
Alamar Capital Management
Alamar Capital Management Santa Barbara, California $196M AUM 74.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

PharVision Advisers's TASK Position: Q3 2026 in Review

PharVision Advisers sold out of TaskUs (TASK) in Q3 2026, closing a stake of 11,056 shares — an estimated $51.7K sold.

PharVision Advisers first reported a position in TASK in Q1 2025 and held it in 3 quarters. The position peaked at $262K in Q4 2025. 27 funds tracked by Wall St. Rank hold TASK as of Q3 2026.

  • PharVision Advisers reported no remaining TaskUs position as of Q3 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,056 TaskUs shares in Q3 2026, an estimated $51.7K.
  • PharVision Advisers first reported a position in TaskUs in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's TaskUs position peaked at $262K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held TaskUs as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.